Official Title
Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS: Open Label, Randomized, Controlled Study
Brief Summary

COVID-19 has a variety of symptoms from asymptomatic respiratory dysfunction to death.Considering the pathophysiology of SARS-CoV-2 and its relationship with the neuroimmunesystem, response, autonomic balance, musculoskeletal and respiratory and neuropsychiatricsymptoms presented by patients, the investigators highlight the potential use ofnon-invasive neuromodulation methods to assess the effectiveness of treating patientswith COVID-19, as these techniques can be useful in the management of important clinicalaspects in the functional recovery of individuals affected by the disease.The investigators intend to evaluate the effects of HD- tDCS to promote ventilatoryweaning in patients admitted to the Intensive Care Unit (ICU) and to improve therespiratory performance of those hospitalized in nursing beds for treatment of COVID -19.

Detailed Description

Not Provided

Unknown status
Coronavirus
COVID-19 Respiratory Infection

Other: Active HD-tDCS 3mA

This group will receive HD-tDCS 3mA intensitie. 0 sessions at ICU simultaneously to
physical rehabilitation. The HD- tDCS will be started with a 30 s ramp-up to the desired
intensity, which was maintained for 20 min.

Other: Sham HD-tDCS

This group will receive sham HD-tDCS. The intervention will be applied in 10 sessions at
ICU simultaneously to physical rehabilitation. The HD- tDCS will be started with a 30 s
ramp-up them turn off.

Eligibility Criteria

Intensive Care Unit's Inclusion Criteria:

Patients of at least 18 years-old with a PCR-confirmed SARS-CoV-2 diagnosis and receiving
mechanical ventilation at least 48 hours of meeting criteria for moderate to severe acute
respiratory distress syndrome (ARDS), under weaning, were enrolled in this study. An ARDS
diagnosis was made according to the Berlin Definition criteria.

Intensive Care Unit's Exclusion Criteria:

Patients were excluded if they had a condition that could prevent adequate performance of
inspiratory muscle training (e.g., neuropathy or myopathy), pregnancy or active
lactation, Richmond Agitation and Sedation Scale (RASS) scores between -2 and + 1,
Glasgow Coma Scale (GCS) ≤ 8, consent refusal, and contraindications to brain stimulation
(e.g., aneurysm clips).

Eligibility Gender
All
Eligibility Age
Minimum: 20 Years ~ Maximum: 90 Years
Countries
Brazil
Locations

Federal University of Paraíba,Department of Psychology
João Pessoa, Paraíba, Brazil

Investigator: Suellen Andrade
Contact: 986046032
suellenandrade@gmail.com

Investigator: Suellen Andrade

Contacts

Suellen Andrade, Phd
986046032 - 5583
suellenandrade@gmail.com

Maria Cecilia Silvestre
996381737 - 5584
ceciliasilvestre.to@gmail.com

Not Provided

Federal University of Paraíba
NCT Number
MeSH Terms
COVID-19
Respiratory Tract Infections